Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Growth 2023-2029

Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Growth 2023-2029

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

LPI (LP Information)' newest research report, the “Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Forecast” looks at past sales and reviews total world Extracorporeal Membrane Oxygenation (ECMO) Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Extracorporeal Membrane Oxygenation (ECMO) Systems sales for 2023 through 2029. With Extracorporeal Membrane Oxygenation (ECMO) Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal Membrane Oxygenation (ECMO) Systems industry.

This Insight Report provides a comprehensive analysis of the global Extracorporeal Membrane Oxygenation (ECMO) Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal Membrane Oxygenation (ECMO) Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Extracorporeal Membrane Oxygenation (ECMO) Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal Membrane Oxygenation (ECMO) Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal Membrane Oxygenation (ECMO) Systems.

The global Extracorporeal Membrane Oxygenation (ECMO) Systems market size is projected to grow from US$ 281 million in 2022 to US$ 355.6 million in 2029; it is expected to grow at a CAGR of 355.6 from 2023 to 2029.

The global extracorporeal membrane oxygenation (ECMO) system market is dominated by North America (41%) and Europe (34%). The market is growing due to improved patient safety and awareness among the doctors and patients. The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.

This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), the Veno Venous (VV) contributed to 61.82% of global market of ECMO system industry.

For China market, the industry is developing rapidly. The main players are Medtronic, Maquet, Sorin, Terumo and Xenios. Medtronic and Maquet enjoy more than 50% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal Membrane Oxygenation (ECMO) Systems market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO

Segmentation by application
Neonatal
Pediatric
Adult

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Maquet
Sorin
Terumo
Xenios

Key Questions Addressed in this Report

What is the 10-year outlook for the global Extracorporeal Membrane Oxygenation (ECMO) Systems market?

What factors are driving Extracorporeal Membrane Oxygenation (ECMO) Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Extracorporeal Membrane Oxygenation (ECMO) Systems market opportunities vary by end market size?

How does Extracorporeal Membrane Oxygenation (ECMO) Systems break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.